Older Adults Face Four Vaccine Decisions This Fall While the Federal Schedule Still Carries a 2025 Date - Medical Daily

Latest News About Osivax and GC Biopharma plan a combined flu vaccine

Osivax and GC Biopharma announced a major partnership to develop a more advanced influenza vaccine. The vaccine is set to combine OVX836 and GC FLU. Osivax secured those rights for pursuing a combination shot.

Older adults must weigh four vaccine decisions this fall, while the federal immunization calendar still lists a 2025 date. Flu and pneumonia deaths have fallen for 25 years, but one American age group saw an increase.

Sources & References